Article

Biotechnology Council of New Jersey Elects New Officers

The Biotechnology Council of New Jersey (Trenton, NJ, www.biotechnj.org) has elected three new members to its board of trustees.

The Biotechnology Council of New Jersey (Trenton, NJ, www.biotechnj.org) has elected three new members to its board of trustees. The new members are: Ulrich M. Grau, PhD, president and CEO of Lux Biosciences, Inc.; Dan Greenleaf, president and CEO of VioQuest Pharmaceuticals, Inc.; and John Maki, president and CEO of Vicus Therapeutics.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
How the 15% US-EU Tariff Cap Affects Bio/pharma
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
© 2025 MJH Life Sciences

All rights reserved.